Blogs

In just a few weeks, scientists willl gather to participate in the “FutureTox: Building the Road for 21st Century Toxicology and Risk Assessment Practices” meeting. FutureTox will address the challenges and opportunities associated with effective and efficient implementation of cutting-edge toxicity testing technologies and tools that will inform hazard prediction and risk assessment. This SOT Contemporary Concepts in Toxicology meeting will be held on October 18–19, 2012, in Arlington, Virginia. In addition to SOT, the Dow Chemical Company, ILSI Health and Environmental Sciences Institute Risk 21, Human Toxicology Project Consortium, and the National Institute of Environmental Health Sciences (NIEHS) are sponsors (sponsorship opportunities still are available). FutureTox will provide information of great relevance to scientists in academia, government, and industry. 

Three session themes are intended to stimulate more detailed dialog and understanding. These themes include (a) Toxicology testing in the 21st Century (TT21c) approaches for safety assessment and expectations for effective and efficient integration into and potential transition of existing safety assessment practices; (b) TT21c approaches for exposure assessments and links to toxicity test dosimetry, with a particular focus on relationships to contextual dose-exposure considerations associated with high throughput in vitro evaluation systems; and finally (c) Reframing risk assessment practices, with an emphasis on how emerging science can best impact and reshape current risk assessment practices.